HALOZYME THERAPEUTICS, INC.: revenue
| Value | {"amount": 660116000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | HALOZYME THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:36:29.993166+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4b990875-14b1-4c99-8223-0badc3cd11f3
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001159036-23-000012Retrieved: 2026-08-19T11:36:29.993166+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001159036/revenue/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4b990875-14b1-4c99-8223-0badc3cd11f3
History
- no predecessors — first report